• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB
Click for more information
2.99% 32.5¢

DIMERIX LIMITED - Charts / Financials

Market Cap $211.6M  ! watchlist Created with Sketch. Add to my watchlist

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.56pm 21/11/2024 (20 minute delay) ?
Day
Open 33.5¢   Day High 33.5¢   Day Low 30.0¢
Daily Volume 1443730
Bids   Sellers
Number Price Volume   Number Price Volume
4 32.5¢ 23447   1 33.5¢ 100000

Directors & Senior Management

Dr. Nina Webster Chief Executive Officer, Managing Director, Director
Mr. Hamish George Chief Financial Officer, Company Secretary
Dr. David Fuller Chief Medical Officer
Dr. Ash Soman Member of the Executive Board
Mr. Mark Diamond Non-Executive Chairman of the Board
Mr. Hugh Alsop Non-Executive Director
Dr. Sonia Maria Poli Non-Executive Director
Mr. Clinton Snow Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
32.5¢ 		Change
-0.010(2.99%) 		Mkt cap ! $211.6M
Open High Low Value Volume
33.5¢ 33.5¢ 30.0¢ $471.6K 1.443M

Buyers (Bids)

No. Vol. Price($)
4 23447 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 100000 1
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
33.0¢ 		  Change
-0.010 ( 2.94 %)
Open High Low Volume
32.5¢ 33.5¢ 30.5¢ 880183
Last updated 15.56pm 21/11/2024 ?

Top Stories

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.